论文部分内容阅读
从2015年1月1日起截至目前,全国共有155家药企GMP证书被收回。另据国家食药监总局公布的数据,截至1月13日,全国有药品生产企业7 179家,有1 795家企业未通过认证。未通过认证及被收回的近2 000家,而按照规定,目前无GMP认证的企业生产车间一律停止生产。据相关业内人士介绍,很多未通过GMP认证的企业都是小企业,因为无法负担成本而放弃GMP认证,部分中药生产企业直接转做保健品市场,而很多靠生产批号过活的
From January 1, 2015 onwards, up to now, a total of 155 pharmaceutical GMP certificates have been withdrawn. According to the data released by the State Food and Drug Administration, as of January 13, there were 7,179 pharmaceutical manufacturers nationwide, and 1,795 enterprises failed to pass the certification. Nearly 2 000 failed to pass the certification and were recovered, and according to the regulations, there is currently no production workshop of GMP certification to stop production. According to relevant industry insiders, many enterprises that fail to pass GMP certification are small businesses that can not afford the GMP because they can not afford the cost. Some Chinese medicine manufacturers switch directly to the market of health products, and many rely on production lot numbers to survive